Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Neola Medical via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Kontakt
Språk
Typ
Språk
Typ
2025-05-07 11:00:00
Two weeks to go – Welcome to Neola Medical’s Annual General Meeting 2025
We warmly invite shareholders and stakeholders to join us at Neola Medical’s headquarters in Lund for the 2025 Annual General Meeting. This is an opportunity to gain deeper insights into our progress, strategic direction, and the year ahead as we continue our journey toward clinical validation
2025-05-06 15:15:00
One week to go – Support Neola Medical in the Pioneer Prize
Neola Medical is proud to be one of eight finalists for Sweden’s new global innovation award – the Pioneer Prize, launched by the Swedish Institute in collaboration with Business Sweden. The prize recognizes small and medium-sized companies offering groundbreaking, scalable solutions that support the green and digital transition
2025-03-27 07:10:00
Surviving the Valley of Death: Neola Medical’s CEO on Walk the Valley Podcast
In this episode of Walk the Valley Podcast, CEO Hanna Sjöström shares her insights on the often underestimated challenges of turning medical device innovations into viable commercial solutions, and why strong IP and promising technology are just the beginning
2025-03-14 10:52:00
Redeye Interview: Neola Medical Strengthens Ownership Base with Institutional Investors
In an interview with Redeye, CEO Hanna Sjöström, discusses the company’s latest capital raise of approximately SEK 20 million and its significance for the future. For the first time, the company has attracted institutional investors, Cicero Funds and Adrigo Funds, while existing major shareholders, including Anmiro AB, have continued to increase their holdings
2025-02-25 07:10:00
“A Major Milestone” – CEO Hanna Sjöström in interview with Life Science Sweden
Neola Medical takes an important step forward in advancing neonatal care. After years of development, the company has received approval to initiate its first clinical study on preterm born babies—a key step in evaluating its continiuos lung monitoring device, Neola®, for this vulnerable patient group. In an interview with Life Science Sweden, CEO Hanna Sjöström discusses the significance of t...
2025-02-14 07:10:00
Redeye Interview with CEO Hanna Sjöström
Following the release of Neola Medical’s Q4 2024 report, Redeye Equity Research Analyst Gustaf Meyer interviewed CEO Hanna Sjöström to discuss key takeaways, the company’s progress toward the clinical phase, and the upcoming first clinical study on preterm born babies in Sweden
2025-02-13 10:38:00
Did you miss Neola Medical’s Q4 report presentation?
Catch up on key insights into Neola Medical’s latest developments as we prepare for clinical studies and continue strengthening our presence in the U.S. market
2022-12-13 10:05:00
Ny intervju med Neola Medicals vd Hanna Sjöström om bolagets marknadsförberedande arbete
I en ny intervju med Direkt Studios berättar vd Hanna Sjöström om bolagets marknadsförberedande arbete. I intervjun berättar vd mer om bland annat bolagets regulatoriska arbete, certifieringen enligt ISO 13485 och det kliniska fokuset
2022-11-30 15:25:00
Neola Medicals Clinical Manger besöker neonatalintensivvårdskliniker i Polen
Bolagets nätverk fortsätter att växa. Clinical Manager Ph.D. MD Tetiana Kovtiukh arbetar med att knyta internationella kontakter med key opinion leaders, både genom konferenser och kliniska besök. Nyligen besökte Dr. Tetiana två neonatalintensivvårdskliniker i Polen, och vi har gjort en kortare intervju med henne för att få veta mer